These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32974151)
1. Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database. Huang KY; Zhang J; Fu WF; Lin YX; Song CG Front Oncol; 2020; 10():1420. PubMed ID: 32974151 [No Abstract] [Full Text] [Related]
2. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study. Ge LP; Liu XY; Xiao Y; Gou ZC; Zhao S; Jiang YZ; Di GH Cancer Manag Res; 2018; 10():4381-4391. PubMed ID: 30349371 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients. Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539 [TBL] [Abstract][Full Text] [Related]
4. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping. Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239 [TBL] [Abstract][Full Text] [Related]
5. Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database. Man X; Xu H; Wang H; Zhao J; Chen X; Yin S; Tan Q; Huang J; Sun S; Zhou D; Zheng F; Liu T; Song L; Zhang B; Li N; Li H Ann Transl Med; 2022 Dec; 10(24):1351. PubMed ID: 36660717 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study. Zhang D; Zhai J; Li L; Wu Y; Ma F; Xu B J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431280 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer. Wang HM; Yu AY; Li LL; Ma LY; Cao MH; Yang YL; Qin XB; Tang JJ; Han ZX World J Psychiatry; 2024 Jan; 14(1):76-87. PubMed ID: 38327892 [TBL] [Abstract][Full Text] [Related]
8. The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis. Johnson HM; Irish W; Vohra NA; Wong JH Breast Cancer Res Treat; 2019 Aug; 177(1):155-164. PubMed ID: 31127469 [TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical characteristics between occult and non-occult breast cancer. Ping S; Ming WH; Bin SH; Wen WD; Cheng Q; Jun CC; Bin HY; Jian CZ J BUON; 2014; 19(3):662-6. PubMed ID: 25261649 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study. Zhao Z; Zhang T; Yao Y; Lu X BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796 [TBL] [Abstract][Full Text] [Related]
11. Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2. Xiao Y; Li J; Wu Z; Zhang X; Ming J Gland Surg; 2022 Jan; 11(1):77-90. PubMed ID: 35242671 [TBL] [Abstract][Full Text] [Related]
12. Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement. Liu Y; He M; Zuo WJ; Hao S; Wang ZH; Shao ZM Front Oncol; 2021; 11():585613. PubMed ID: 33898305 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer. Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database. Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045 [TBL] [Abstract][Full Text] [Related]
15. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis. Lin Y; Huang K; Zeng Q; Zhang J; Song C PeerJ; 2020; 8():e8694. PubMed ID: 32219021 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database. Kim BH; Kwon J; Kim K Cancer Res Treat; 2018 Apr; 50(2):551-561. PubMed ID: 28602055 [TBL] [Abstract][Full Text] [Related]
17. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis. Lian W; Zheng J; Chen D Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209 [TBL] [Abstract][Full Text] [Related]
18. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study. Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883 [TBL] [Abstract][Full Text] [Related]
19. The Prognostic Significance of the Oncotype DX Recurrence Score in T Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]